Williams John W, Stellato Christina Perez, Cornell John, Barrett James E
Center for Health Services Research in Primary Care, Department of Veterans Affairs Medical Center, Duke University Medical Center, Durham, North Carolina 27705, USA.
Int J Psychiatry Med. 2004;34(1):37-50. doi: 10.2190/U1B0-NKWC-568V-4MAK.
Depression scales that are responsive to changes in clinical symptoms are important for clinical monitoring and outcomes assessment in longitudinal studies. We evaluated the psychometric properties and responsiveness to clinical change of the 13- and 20-item versions of the Hopkins Symptom Checklist Depression Scale (HSCL-D).
A secondary data analysis from a large 11-week, multicenter clinical trial, comparing three treatments was performed. Adult patients with minor depression or dysthymia and a score of > or = 10 on the Hamilton Depression Rating Scale (HDRS) were recruited from primary care clinics. Item-total correlations and Cronbach alphas were computed for HSCL-D-13 and HSCL-D-20. Clinical response at 11 weeks was defined by a Hamilton Depression Rating Scale (HDRS) < 10, clinical remission by a HDRS < 7, and criterion symptom remission by < or = 1 DSM-III-R criterion symptoms. Standardized effect sizes and Guyatt's responsiveness statistic were determined for the 13- and 20-item HSCL-D.
Of the 656 subjects enrolled, 511 (77.9%) had complete data and were included in the analysis. Patients were 61.1 +/- 15.0 years old; minor depression was diagnosed in 238, dysthymia in 273. Both scales had good internal consistency; Cronbach's alpha = 0.835 and 0.859 for the 13- and 20-items questionnaires respectively. Standardized effect sizes for clinical response (0.62 for the HSCL-D-13; 0.66 for the HSCL-D-20), clinical remission (0.69 and 0.70), and criterion symptom remission (0.65 and 0.67) showed moderate to large effects and did not differ significantly for the two versions. Responsiveness was virtually identical for patients with minor depression and dysthymia but responsiveness was substantially lower for ethnic minorities.
The HSCL-D-13 and 20-item versions have similar responsiveness to change. For use in European Americans, we recommend the HSCL-D-13 if response burden is the preeminent consideration. To more fully capture DSM criterion symptoms, we recommend the HSCL-D-20.
对临床症状变化有反应的抑郁量表对于纵向研究中的临床监测和结果评估至关重要。我们评估了霍普金斯症状清单抑郁量表(HSCL-D)13项和20项版本的心理测量特性及对临床变化的反应性。
对一项为期11周的大型多中心临床试验进行二次数据分析,该试验比较了三种治疗方法。从初级保健诊所招募汉密尔顿抑郁量表(HDRS)评分≥10分的轻度抑郁或心境恶劣的成年患者。计算HSCL-D-13和HSCL-D-20的项目-总分相关性和克朗巴哈系数。11周时的临床反应定义为汉密尔顿抑郁量表(HDRS)<10分,临床缓解定义为HDRS<7分,标准症状缓解定义为≤1条DSM-III-R标准症状。确定13项和20项HSCL-D的标准化效应量和盖亚特反应性统计量。
在纳入的656名受试者中,511名(77.9%)有完整数据并纳入分析。患者年龄为61.1±15.0岁;238例诊断为轻度抑郁,273例诊断为心境恶劣。两个量表都有良好的内部一致性;13项和20项问卷的克朗巴哈系数分别为0.835和0.859。临床反应(HSCL-D-13为0.62;HSCL-D-20为0.66)、临床缓解(0.69和0.70)和标准症状缓解(0.65和0.67)的标准化效应量显示出中度至较大的效应,两个版本之间无显著差异。轻度抑郁和心境恶劣患者的反应性几乎相同,但少数民族患者的反应性明显较低。
HSCL-D-13和20项版本对变化的反应性相似。对于欧裔美国人,如果首要考虑反应负担,我们推荐HSCL-D-13。为了更全面地捕捉DSM标准症状,我们推荐HSCL-D-20。